查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1288666

全球可吸收抗菌包膜市场研究报告 - 行业分析、规模、份额、增长、趋势和2023年至2030年预测

Global Absorbable Antibacterial Envelope Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 139 Pages | 商品交期: 最快1-2个工作天内

价格

据推测，到2030年，全球对可吸收抗菌包膜的需求将从2022年的35.94百万美元达到近71.82百万美元的市场规模，在2023-2030年的研究期间，年复合增长率为9.04%。

可吸收的抗菌封套是一种医疗设备，可以减少接受心脏植入手术的病人的感染风险，如心脏起搏器或除颤器的植入。该设备由一种生物可吸收的聚合物基质制成，其中含有抗生素，如米诺环素和利福平，在植入后的几周内逐渐释放。可吸收抗菌包膜在手术时被放置在可植入装置的周围，旨在为装置和周围组织之间提供一个物理屏障。封套内的抗生素会随着时间的推移缓慢释放，有助于防止植入部位的感染。该装置通常用于有高风险的病人，如那些以前在心脏植入部位有感染的病人，或那些有潜在医疗条件使他们更容易受到感染的病人。可吸收抗菌包膜是心脏植入领域的一项重要进展，因为植入部位的感染可能很严重，并可能威胁到生命。使用该封套可以帮助减少这些感染的发生率，从而改善病人的治疗效果，降低医疗费用。

市场动态：

心血管疾病的发病率越来越高，加上人口老龄化，正在推动对心脏植入手术的需求。这推动了对可吸收抗菌包膜的需求，这种包膜用于防止植入部位的感染。心脏植入部位的感染可能是严重的，并威胁到生命。事实证明，使用可吸收抗菌包膜可以减少这些感染的发生率，从而导致对这些设备的需求增加。开发更先进、更有效的可吸收抗菌包膜在预防感染方面更有效，而且比早期版本的副作用更少。可吸收抗菌包膜的好处，如减少感染风险和缩短住院时间，在病人和医疗机构中越来越为人所知。这正在推动对这些设备的需求。世界各国政府都在鼓励采用抗菌医疗设备，包括可吸收抗菌封套，以减少感染的发生率和改善病人的治疗效果。

该研究报告包括波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清楚地了解行业结构，并在全球范围内评估竞争的吸引力。此外，这些工具还对全球可吸收抗菌包膜市场的每个细分市场进行了全面评估。可吸收抗菌包膜行业的增长和趋势为这项研究提供了一个整体的方法。

区域分析：

本节涵盖了区域前景，强调了北美、欧洲、亚太、拉丁美洲以及中东和非洲地区对可吸收抗菌包膜市场的当前和未来需求。此外，该报告重点关注所有突出地区的各个应用部门的需求、估计和预测。

该研究报告还涵盖了市场中主要参与者的全面概况和对全球竞争格局的深入看法。可吸收抗菌包膜市场的主要参与者包括Medtronic plc和Aziyo Biologics, Inc。这一部分包括对竞争格局的整体看法，其中包括各种战略发展，如主要的合併和收购，未来的能力，伙伴关系，财务概况，合作，新产品的开发，新产品的推出，以及其他发展。

目录

第1章：前言

  • 报告描述
    • 目的
    • 目标受众
    • 独特的销售主张（USP）和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法

第二章：执行摘要

  • 市场的亮点
  • 全球市场简介

第三章：可吸收抗菌包膜 - 行业分析

  • 简介 - 市场动态
  • 市场驱动力
  • 市场限制因素
  • 机会
  • 行业趋势
  • 波特的五力分析
  • 市场吸引力分析
    • 市场吸引力分析：按应用
    • 市场吸引力分析：按终端用户
    • 市场吸引力分析：按地区

第四章：价值链分析

  • 价值链分析
  • 原材料分析
    • 原材料清单
    • 原材料制造商名单
    • 关键原材料的价格趋势
  • 潜在买家名单
  • 营销渠道
    • 直接营销
    • 间接营销
    • 营销渠道的发展趋势

第五章：Covid-19疫情的影响分析

  • Covid-19疫情的影响分析
    • 对生产的直接影响
    • 供应链和市场的破坏
    • 对企业和金融市场的财务影响
  • 按生产、进口、出口和需求分析COVID-19的影响
  • 市场：COVID-19之前和之后
  • 冠状病毒（COVID-19）疫情的估计影响
  • COVID-19：微观和宏观因素分析

第六章：全球可吸收抗菌包膜市场分析：按应用分类

  • 概述：按应用分类
  • 历史和预测数据
  • 分析：按应用分类
  • 心脏再同步化治疗除颤器（CRT-D）
  • 植入式心律转复除颤器(ICD)
  • 心脏再同步化治疗起搏器（CRT-P）。

第7章 ：全球可吸收抗菌包膜市场分析：按终端用户分类

  • 按终端用户概述
  • 历史和预测数据
  • 按终端用户分析
  • 医院
  • 非住院手术中心（ASCs）
  • 其他

第八章：全球可吸收抗菌包膜市场分析：按地域划分

  • 区域展望
  • 简介
  • 北美洲销售分析
    • 概述，历史和预测的销售分析
    • 北美地区分部销售分析
    • 北美地区国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概况、历史和预测的销售分析
    • 欧洲分部销售分析
    • 欧洲国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 意大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概况、历史和预测的销售分析
    • 亚太地区分部销售分析
    • 亚太地区国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳大利亚销售分析
    • 亚太其他地区销售分析
  • 拉美地区销售分析
    • 概况、历史和预测的销售分析
    • 拉美地区分部销售分析
    • 拉美地区国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉美其他地区销售分析
  • 中东和非洲销售分析
    • 概况、历史和预测销售分析
    • 中东和非洲地区分部销售分析
    • 中东和非洲国家销售分析
    • 沙特阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东和非洲其他地区销售分析

第九章：可吸收抗菌包膜企业的竞争格局

  • 可吸收的抗菌包膜市场竞争
  • 伙伴关系/合作/协议
  • 合併和收购
  • 新产品发布
  • 其他方面的发展

第十章：公司简介

  • 顶级公司的市场份额分析
  • 市场集中度
  • Medtronic plc
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Aziyo Biologics Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展情况

注意 - 在公司简介中，财务细节和最近的发展情况要视情况而定，如果是私营公司，可能不包括在内。

Product Code: VMR112110509

The global demand for Absorbable Antibacterial Envelope Market is presumed to reach the market size of nearly USD 71.82 MN by 2030 from USD 35.94 MN in 2022 with a CAGR of 9.04% under the study period 2023-2030.

An absorbable antibacterial envelope is a medical device that reduces the risk of infections in patients undergoing cardiac implant procedures, such as pacemakers or defibrillator implantation. The device is made of a bio-absorbable polymer matrix that contains antibiotics, such as minocycline and rifampin, which are released gradually over a period of several weeks after implantation. The Absorbable Antibacterial Envelope is placed around the implantable device at the time of the procedure and is designed to provide a physical barrier between the device and surrounding tissue. The antibiotics within the envelope are released slowly over time, helping to prevent infection at the site of the implant. The device is typically used in patients who are at a high risk of developing infections, such as those who have previously had infections at the site of a cardiac implant or those who have underlying medical conditions that make them more susceptible to infections. The Absorbable Antibacterial Envelope is an important advancement in the field of cardiac implantation, as infections at the site of the implant can be serious and potentially life-threatening. The use of the envelope can help to reduce the incidence of these infections, leading to better patient outcomes and reduced healthcare costs.

Market Dynamics:

The growing incidence of cardiovascular disease, coupled with an aging population, is driving the demand for cardiac implant procedures. This is driving the demand for absorbable antibacterial envelopes, which are used to prevent infections at the site of the implant. Infections at the site of cardiac implants can be serious and life-threatening. The use of absorbable antibacterial envelopes has been shown to reduce the incidence of these infections, leading to increased demand for these devices. Development of more advanced and effective absorbable antibacterial envelopes are more effective at preventing infections and have fewer side effects than earlier versions. The benefits of absorbable antibacterial envelopes, such as the reduced risk of infection and shorter hospital stays, are becoming increasingly well-known among patients and healthcare providers. This is driving the demand for these devices. Governments around the world are encouraging the adoption of antibacterial medical devices, including absorbable antibacterial envelopes, to reduce the incidence of infections and improve patient outcomes.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of absorbable antibacterial envelope. The growth and trends of absorbable antibacterial envelope industry provide a holistic approach to this study.

Market Segmentation:

This section of the absorbable antibacterial envelope market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

  • Cardiac Resynchronization Therapy Defibrillators (CRT-D)
  • Implantable Cardioverter Defibrillators (Icd)
  • Cardiac Resynchronization Therapy Pacemakers (CRT-P)

By End-User

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Others

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Absorbable Antibacterial Envelope market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the absorbable antibacterial envelope market include Medtronic plc and Aziyo Biologics, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . ABSORBABLE ANTIBACTERIAL ENVELOPE - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Application
    • 3.7.2 Market Attractiveness Analysis By End-user
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 5.1. Impact Analysis of Covid-19 Outbreak
    • 5.1.1. Direct Impact on Production
    • 5.1.2. Supply Chain and Market Disruption
    • 5.1.3. Financial Impact on Firms and Financial Markets
  • 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 5.3. Market: Pre V/S Post COVID-19
  • 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
  • 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL ABSORBABLE ANTIBACTERIAL ENVELOPE MARKET ANALYSIS BY APPLICATION

  • 6.1 Overview by Application
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Application
  • 6.4 Cardiac Resynchronization Therapy Defibrillators (CRT-D) Historic and Forecast Sales by Regions
  • 6.5 Implantable Cardioverter Defibrillators (ICD) Historic and Forecast Sales by Regions
  • 6.6 Cardiac Resynchronization Therapy Pacemakers (CRT-P) Historic and Forecast Sales by Regions

7 . GLOBAL ABSORBABLE ANTIBACTERIAL ENVELOPE MARKET ANALYSIS BY END-USER

  • 7.1 Overview by End-user
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by End-user
  • 7.4 Hospitals Historic and Forecast Sales by Regions
  • 7.5 Ambulatory Surgical Centers (ASCs) Historic and Forecast Sales by Regions
  • 7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL ABSORBABLE ANTIBACTERIAL ENVELOPE MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE ABSORBABLE ANTIBACTERIAL ENVELOPE COMPANIES

  • 9.1. Absorbable Antibacterial Envelope Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF ABSORBABLE ANTIBACTERIAL ENVELOPE INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Medtronic plc
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Aziyo Biologics Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Application (USD MN)
  • Cardiac Resynchronization Therapy Defibrillators (CRT-D) Market Sales by Geography (USD MN)
  • Implantable Cardioverter Defibrillators (ICD) Market Sales by Geography (USD MN)
  • Cardiac Resynchronization Therapy Pacemakers (CRT-P) Market Sales by Geography (USD MN)
  • Analysis Market by End-user (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Ambulatory Surgical Centers (ASCs) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Absorbable Antibacterial Envelope Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Absorbable Antibacterial Envelope Report
  • Market Research Process
  • Market Research Methodology
  • Global Absorbable Antibacterial Envelope Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End-user
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Application (USD MN)
  • Cardiac Resynchronization Therapy Defibrillators (CRT-D) Market Sales by Geography (USD MN)
  • Implantable Cardioverter Defibrillators (ICD) Market Sales by Geography (USD MN)
  • Cardiac Resynchronization Therapy Pacemakers (CRT-P) Market Sales by Geography (USD MN)
  • Global Market Analysis by End-user (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Ambulatory Surgical Centers (ASCs) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Companies Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.